Antiproliferative Factor Signaling and Interstitial Cystitis/Painful Bladder Syndrome

키워드

참고문헌 (84)

1. Hanno P, "Diagnosis of interstitial cystitis", J Urol, 143, pp.278~281 (1990)
2. Hanno P, "International Consultation on IC - Rome, September 2004", Forging an International Consensus: progress in painful bladder syndrome, Int Urogynecol J Pelvic Floor Dysfunct, pp.2005, 16(Suppl 1)[DOI]
3. Parsons CL, "Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis)", J Urol, 145, pp.732~735 (1991)
4. Sant GR, "Interstitial cystitis: current issues and controversies in diagnosis", Urology, 57(6 Suppl 1), pp.82~88 (2001)
5. Nordling J, "Primary evaluation of patients suspected of having interstitial cystitis (IC)", Eur Urol, 45, pp.662~669 (2004)
6. Bogart LM, "Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review", J Urol, 177, pp.450~456 (2007)
7. Tomaszewski JE, "Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study", Urology, 57(6 Suppl 1), pp.67~81 (2001)
8. Phatak S, "The management of interstitial cystitis: an update", Nat Clin Pract Urol, 3, pp.45~53 (2006)
9. Warren JW, "Interstitial cystitis", Curr Opin Urol, 12, pp.69~74 (2002)
10. Berry SH, "Prevalence of symptoms of bladder pain syndrome", interstitial cystitis among adult females in the United States, 2011, pp.186, 540~544
11. Moutzouris DA, "Interstitial cystitis: an unsolved enigma", Clin J Am Soc Nephrol, 4, pp.1844~1857 (2009)
12. "Neurourol Urodyn", 2009, 907~
13. Johansson SL, "Clinical features and spectrum of light microscopic changes in interstitial cystitis", J Urol, 143, pp.1118~1124 (1990)
14. Ottem DP, "What is the value of cystoscopy with hydrodistension for interstitial cystitis", Urology, 66, pp.494~499 (2005)
15. Parsons CL, "The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis", J Urol, 159, pp.1862~1866 (1998)
16. Persu C, "From interstitial cystitis to chronic pelvic pain", J Med Life, 3, pp.167~174 (2010)
17. Hanno PM, "AUA guideline for the diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2011, pp.185, 2162~2170
18. Hanno PM, "Analysis of long-term Elmiron therapy for interstitial cystitis", Urology, 49(5A Suppl), pp.93~99 (1997)
19. Bouchelouche K, "Recent developments in the management of interstitial cystitis", Curr Opin Urol, 13, pp.309~313 (2003)
20. Erickson DR, "A comparison of multiple urine markers for interstitial cystitis", J Urol, 167, pp.2461~2469 (2002)
21. Keay S, "A diagnostic in vitro urine assay for interstitial cystitis", Urology, 52, pp.974~978 (1998)
22. Moldwin RM, "Rational approaches to the treatment of patients with interstitial cystitis", Urology, 69(4 Suppl), pp.73~81 (2007)
23. Slobodov G, "Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis", J Urol, 171, pp.1554~1558 (2004)
24. Keay SK, "An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide", Proc Natl Acad Sci U S A, 101, pp.11803~11808 (2004)
25. Keay S, "Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor: sensitive and specific urine markers for interstitial cystitis", Urology, 57(6 Suppl 1), pp.104~ (2001)
26. Kim JC, "Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder", J Urol, 175, pp.1773~1776 (2006)
27. Liu HT, "Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis", bladder pain syndrome and detrusor overactivity, 2010, pp.106, 1681~1685
28. Nazif O, "Neural upregulation in interstitial cystitis", Urology, 69(4 Suppl), pp.24~33 (2007)
29. Chai TC, "New theories in interstitial cystitis", Nat Clin Pract Urol, 1, pp.85~89 (2004)
30. Kushner L, "Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail", Urology, 57(6 Suppl 1), pp.129~ (2001)
31. Sanchez Freire V, "MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome", Am J Pathol, 176, pp.288~303 (2010)
32. Birder LA, "Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis", J Urol, 173, pp.625~629 (2005)
33. Jacobs BL, "Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients", Can J Urol, 17, pp.4989~4994 (2010)
34. Keay S, "Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls", J Urol, 158, pp.1983~1988 (1997)
35. Ongusaha PP, "HB-EGF is a potent inducer of tumor growth and angiogenesis", Cancer Res, 64, pp.5283~5290 (2004)
36. Freeman MR, "Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder", J Clin Invest, 99, pp.1028~1036 (1997)
37. Schneider MR, "The epidermal growth factor receptor ligands at a glance", J Cell Physiol, 218, pp.460~466 (2009)
38. Kim J, "Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress", Cancer Res, 65, pp.8242~8249 (2005)
39. Keay S, "Cell signaling in interstitial cystitis", painful bladder syndrome, 2008, pp.20, 2174~2179
40. Keay S, "Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis", Urology, 61, pp.1278~1284 (2003)
41. Keay S, "Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production", J Urol, 164, pp.2112~2118 (2000)
42. Shahjee HM, "Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells", J Exp Clin Cancer Res, 29, pp.160~ (2010)
43. Keay S, "Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis", painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor, 2011, pp.77, 421~430
44. Keay S, "Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients", J Urol, 156, pp.2073~2078 (1996)
45. Keay S, "Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment", Physiol Genomics, 14, pp.107~115 (2003)
46. 이택, "New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs", International Neurourology Journal, 15(2), pp.59~60 (2011), 대한배뇨장애요실금학회
47. Rudick CN, "Mast cell-derived histamine mediates cystitis pain", PLoS One, 3, pp.e2096~ (2008)
48. Shie JH, "Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis", painful bladder syndrome, 2011, pp.108(2 Pt 2), E136~E141
49. Planey SL, "Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling", Mol Biol Cell, 20, pp.1454~1463 (2009)
50. Conrads TP, "CKAP4", p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients, 2006, pp.281, 37836~37843
51. Kim J, "Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation", BJU Int, 103, pp.541~546 (2009)
52. Kim J, "p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells", FEBS Lett, 581, pp.3795~3799 (2007)
53. Yang W, "Quantitative proteomics identifies a beta-catenin network as an element of the signaling response to Frizzled-8 protein-related antiproliferative factor", Mol Cell Proteomics, 10, pp.M110~7492 (2011)
54. Zhang J, "Identification of CKAP4", p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method, 2008, pp.7, 1378~1388
55. Resh MD, "Palmitoylation of ligands, receptors, and intracellular signaling molecules", Sci STKE, 2006, pp.re14~ (2006)
56. Zhang CO, "Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis", J Urol, 174, pp.2382~2387 (2005)
57. Kim J, "Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation", Cancer Res, 62, pp.1549~1554 (2002)
58. Swiatkowski S, "Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines", Exp Cell Res, 282, pp.48~57 (2003)
59. Li Z, "c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells", Urol Oncol, (25) (2011)
60. Ching CB, "Expanding therapeutic targets in bladder cancer: the PI3K", Akt, Lab Invest, pp.2010, 90[DOI]
61. Hers I, "Akt signalling in health and disease", Cell Signal, 23, pp.1515~1527 (2011)
62. Dillon RL, "Distinct biological roles for the akt family in mammary tumor progression", Cancer Res, 70, pp.4260~4264 (2010)
63. Gonzalez E, "The Akt kinases: isoform specificity in metabolism and cancer", Cell Cycle, 8, pp.2502~2508 (2009)
64. Bozulic L, "PIKKing on PKB: regulation of PKB activity by phosphorylation", Curr Opin Cell Biol, 21, pp.256~261 (2009)
65. Bozulic L, "PIKKing on PKB: regulation of PKB activity by phosphorylation", Curr Opin Cell Biol, 21, pp.256~261 (2009)
66. Knowles MA, "Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer", Cancer Metastasis Rev, 28, pp.305~316 (2009)
67. Adam RM, "Signaling through PI3K", Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells, 2003, pp.169, 2388~2393
68. Braithwaite AW, "Some p53-binding proteins that can function as arbiters of life and death", Cell Death Differ, 13, pp.984~993 (2006)
69. Bunz F, "Requirement for p53 and p21 to sustain G2 arrest after DNA damage", Science, 282, pp.1497~1501 (1998)
70. Chèe P, "Inhibiting the p53-MDM2 interaction: an important target for cancer therapy", Nat Rev Cancer, 3, pp.102~109 (2003)
71. Sun Y, "p53 and its downstream proteins as molecular targets of cancer", Mol Carcinog, 45, pp.409~415 (2006)
72. Toledo F, "Regulating the p53 pathway: in vitro hypotheses, in vivo veritas", Nat Rev Cancer, 6, pp.909~923 (2006)
73. Harris SL, "The p53 pathway: positive and negative feedback loops", Oncogene, 24, pp.2899~2908 (2005)
74. Haupt Y, "Mdm2 promotes the rapid degradation of p53", Nature, 387, pp.296~299 (1997)
75. Cooper MJ, "p53 mutations in bladder carcinoma cell lines", Oncol Res, 6, pp.569~579 (1994)
76. Lane DP, "Exploiting the p53 pathway for the diagnosis and therapy of human cancer", Cold Spring Harb Symp Quant Biol, 70, pp.489~497 (2005)
77. Chen L, "ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage", EMBO J, 24, pp.3411~3422 (2005)
78. Cummins JM, "HAUSP is required for p53 destabilization", Cell Cycle, 3, pp.689~692 (2004)
79. Khanna KK, "ATM associates with and phosphorylates p53: mapping the region of interaction", Nat Genet, 20, pp.398~400 (1998)
80. Moumen A, "hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage", Cell, 123, pp.1065~1078 (2005)
81. Meek DW, "The regulation of MDM2 by multisite phosphorylation-opportunities for molecular-based intervention to target tumours", Semin Cancer Biol, 20, pp.19~28 (2010)
82. MacLaine NJ, "How phosphorylation controls p53", Cell Cycle, 10, pp.916~921 (2011)
83. Van QN, "The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis", Dis Markers, 19, pp.169~183 (2003)
84. Chai TC, "Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis", J Urol, 163, pp.1440~1444 (2000)

관련 논문AI추천